Drugs & Therapy Perspectives | 2001(17) articles
- Amprenavir: an option for HIV patients failing treatment with other protease inhibitors?
- β-Blockers are best antiarrhythmics for reducing post-MI mortality
- An improving outlook for patients with postherpetic neuralgia
- The aetiology of antiretroviral-associated lipodystrophy remains elusive posing problems for its prevention and treatment
- First reports of adverse drug reactions (ADRs) in recent weeks
- New in the marketplace